{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T07:57:30Z","timestamp":1792828650232,"version":"4.5.0"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>The features of long-term remission in acromegaly adenomectomy are incompletely understood. An intraoperative predictor for long-term outcome would be valuable for assessing resection of growth hormone (GH)\u2013secreting tumors in real-time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether intraoperative GH measurement could predict long-term outcomes for acromegaly.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>In 47 patients, peripheral blood GH levels were measured thrice intraoperatively: once before tumor dissection, once during tumor dissection, and once after tumor dissection. Long-term remission was defined by age-appropriate, normalized insulin-like growth factor-1 at most recent follow-up and a random GH less than 1.0 ng\/mL. Patients were only considered to be in long-term remission without the use of postoperative medical therapy for acromegaly or radiation therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      The median length of follow-up was 4.51 (range: 0.78-9.80) years. Long-term remission was achieved in 61.7% (29\/47) of operations. Like previous studies, cavernous sinus invasion (odds ratio [OR]: 0.060; 95% CI: 0.014-0.260;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; .01), suprasellar extension (OR: 0.191; 95% CI: 0.053-0.681;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value&lt;.01), and tumor size greater than 1 cm (OR: 0.177; 95% CI: 0.003-0.917;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value = .03) were associated with not being in long-term remission. The minimum GH measured intraoperatively predicted long-term outcome (area under the curve: 0.7107; 95% CI: 0.537-0.884;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; .01). The odds ratio of remission in patients with the lowest quartile minimum intraoperative GH compared with patients with the highest quartile minimum intraoperative GH was 27.0 (95% CI: 2.343-311.171;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      value &lt; .01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Minimum intraoperative GH may predict long-term outcome for acromegaly, which in principle could provide the pituitary neurosurgeon with real-time feedback and inform intraoperative decision making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1227\/ons.0000000000000421","type":"journal-article","created":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T10:00:08Z","timestamp":1667296808000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Intraoperative Prediction of Long-Term Remission in Acromegaly"],"prefix":"10.1227","volume":"24","author":[{"given":"Marcus A.","family":"Zachariah","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, University of Mississippi Medical Center, Jackson, Mississippi, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan J.","family":"Bozer","sequence":"additional","affiliation":[{"name":"College of Medicine, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santino","family":"Cua","sequence":"additional","affiliation":[{"name":"College of Medicine, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano M.","family":"Prevedello","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luma M.","family":"Ghalib","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Hardesty","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo L.","family":"Carrau","sequence":"additional","affiliation":[{"name":"Head and Neck Surgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence S.","family":"Kirschner","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Prevedello","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,11,1]]},"reference":[{"issue":"24","key":"R1-20250820","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med."},{"issue":"3","key":"R2-20250820","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"1","key":"R3-20250820","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary."},{"issue":"11","key":"R4-20250820","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"R5-20250820","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1210\/er.2002-0022","article-title":"Systemic complications of acromegaly","volume":"25","author":"Colao","year":"2004","journal-title":"Endocr Rev."},{"issue":"10","key":"R6-20250820","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly","volume":"83","author":"Swearingen","year":"1998","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"R7-20250820","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1046\/j.1365-2265.2003.01679.x","article-title":"Long-term outcome and mortality after transsphenoidal adenomectomy for acromegaly","volume":"58","author":"Beauregard","year":"2003","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"4","key":"R8-20250820","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2010.7.FOCUS10173","article-title":"Endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas","volume":"29","author":"Hofstetter","year":"2010","journal-title":"Neurosurg Focus."},{"issue":"2","key":"R9-20250820","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"R10-20250820","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","journal-title":"Endocr Relat Cancer."},{"issue":"1","key":"R11-20250820","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11102-017-0797-7","article-title":"Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities","volume":"20","author":"Pivonello","year":"2017","journal-title":"Pituitary."},{"issue":"11","key":"R12-20250820","doi-asserted-by":"crossref","first-page":"4003","DOI":"10.1210\/jc.2014-2900","article-title":"Surgical interventions and medical treatments in treatment-na\u00efve patients with acromegaly","volume":"99","author":"Abu Dabrh","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"R13-20250820","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00701-016-2903-4","article-title":"Surgical treatment of acromegaly according to the 2010 remission criteria: systematic review and meta-analysis","volume":"158","author":"Starnoni","year":"2016","journal-title":"Acta Neurochir (Wien)."},{"issue":"1","key":"R14-20250820","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.wneu.2013.01.021","article-title":"Transsphenoidal surgery for growth hormone-secreting pituitary adenomas in 130 patients","volume":"81","author":"Shirvani","year":"2014","journal-title":"World Neurosurg."},{"issue":"12","key":"R15-20250820","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2014-2670","article-title":"Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic","volume":"99","author":"Mercado","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"R16-20250820","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1210\/clinem\/dgab069","article-title":"Predictors for remission after transsphenoidal surgery in acromegaly: a Dutch Multicenter Study","volume":"106","author":"Coopmans","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"R17-20250820","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11102-020-01063-x","article-title":"Prognostic factors of biochemical remission after transsphenoidal surgery for acromegaly: a structured review","volume":"23","author":"Agrawal","year":"2020","journal-title":"Pituitary."},{"issue":"6","key":"R18-20250820","first-page":"1239","article-title":"Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients","volume":"48","author":"Shimon","year":"2001","journal-title":"Neurosurgery."},{"issue":"2","key":"R19-20250820","first-page":"187","article-title":"The multimodal management of GH-secreting pituitary adenomas: predictive factors, strategies and outcomes","volume":"9","author":"Buliman","year":"2016","journal-title":"J Med Life."},{"issue":"2","key":"R20-20250820","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/neuros\/nyx020","article-title":"Long-Term Endocrine outcomes following endoscopic endonasal transsphenoidal surgery for acromegaly and associated prognostic factors","volume":"81","author":"Babu","year":"2017","journal-title":"Neurosurgery."},{"issue":"5","key":"R21-20250820","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1227\/NEU.0b013e31823f5c16","article-title":"Predicting long-term remission by measuring immediate postoperative growth hormone levels and oral glucose tolerance test in acromegaly","volume":"70","author":"Kim","year":"2012","journal-title":"Neurosurgery."},{"issue":"4","key":"R22-20250820","doi-asserted-by":"crossref","first-page":"719","DOI":"10.3171\/jns.2003.98.4.0719","article-title":"Assessment of long-term remission of acromegaly following surgery","volume":"98","author":"Krieger","year":"2003","journal-title":"J Neurosurg."},{"key":"R23-20250820","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.wneu.2017.05.162","article-title":"Intraoperative scoring system to predict postoperative remission in endoscopic endonasal transsphenoidal surgery for growth hormone-secreting pituitary adenomas","volume":"105","author":"Yano","year":"2017","journal-title":"World Neurosurg."},{"issue":"1","key":"R24-20250820","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1046\/j.1365-2265.1999.00591.x","article-title":"Recent primary transnasal surgical outcomes associated with intraoperative growth hormone measurement in acromegaly","volume":"50","author":"Abe","year":"1999","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"8","key":"R25-20250820","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2176\/nmc.52.558","article-title":"Rapid growth hormone measurement during transsphenoidal surgery: analysis of 252 acromegalic patients","volume":"52","author":"Otani","year":"2012","journal-title":"Neurol Med Chir (Tokyo)."},{"issue":"1","key":"R26-20250820","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.1998.00436.x","article-title":"Can intra-operative GH measurement in acromegalic subjects predict completeness of surgery?","volume":"49","author":"van den Berg","year":"1998","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"6","key":"R27-20250820","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/00365510152567103","article-title":"Evaluation of surgery for acromegaly: role of intraoperative growth hormone measurement?","volume":"61","author":"Valdemarsson","year":"2001","journal-title":"Scand J Clin Lab Invest."},{"issue":"7","key":"R28-20250820","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1210\/jc.2009-2670","article-title":"A consensus on criteria for cure of acromegaly","volume":"95","author":"Giustina","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"issue":"11","key":"R29-20250820","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab."}],"container-title":["Operative Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1227\/ons.0000000000000421","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T17:01:11Z","timestamp":1786122071000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1227\/ons.0000000000000421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1227\/ons.0000000000000421","relation":{},"ISSN":["2332-4252","2332-4260"],"issn-type":[{"value":"2332-4252","type":"print"},{"value":"2332-4260","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,1]]},"assertion":[{"value":"2022-03-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-14","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}